Recently, a number of studies have shown PIK3CA mutations in eutopic endometrial glands in women with and without EAOCs and endometriosis, suggesting that these mutations may confer a survival advantage, allowing for a clonal expansion of these cells at the ectopic sites and are not sole direct driver of tumorigenesis. This evidence concerns the gene PIK3CA and endometriosis.